Case Control Study
Copyright ©The Author(s) 2022.
World J Crit Care Med. May 9, 2022; 11(3): 139-148
Published online May 9, 2022. doi: 10.5492/wjccm.v11.i3.139
Table 2 Microbial profile in the patients' groups

EOS group (n = 30)
LOS group (n = 30)
Total (n =60)
t
P value
Gram-negative bacteriaTotal21 (70.0%)28 (93.3%)49 (81.67%)2.3 < 0.01
Klebsiella15 (50%)20 (67%)35 (58%)1.3NS
E. coli4 (13.30%)1 (3.3%)5 (8.33%)-1.4NS
Acinetobacter2 (6.66%)4 (13.30%)6 (10%)0.85NS
Serratia0%1 (3.3%)1 (1.66%)
Pseudomonas0%2 (6.66%)2 (3.33%)
Gram-positive bacteriaTotal8 (26.7%)2 (6.7%)10 (16.7%)-2.07< 0.01
Group B Streptococcus5 (16.60%)0%5 (8.33%)
CoNS2 (6.66%)1 (3.3%)3 (5%)-0.6NS
Enterococcus1 (3.3%)0%1 (1.66%)
MRSA0%1 (3.3%)1 (1.66%)
Candida1 (3.3%)0%1 (1.66%)